$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000109980017000013 Filed on April 28, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$883.5M	$697.3M
YoY Change	26.7%	18.13%
Cost Of Revenue	$215.6M	$180.3M
YoY Change	19.58%	32.57%
Gross Profit	$667.9M	$517.0M
YoY Change	29.19%	13.8%
Gross Profit Margin	75.6%	74.14%
Selling, General & Admin	$229.6M	$212.7M
YoY Change	7.95%	5.04%
% of Gross Profit	34.38%	41.14%
Research & Development	$128.7M	$101.8M
YoY Change	26.42%	17.82%
% of Gross Profit	19.27%	19.69%
Depreciation & Amortization	$21.10M	$15.90M
YoY Change	32.7%	-0.63%
% of Gross Profit	3.16%	3.08%
Operating Expenses	$358.3M	$314.5M
YoY Change	13.93%	8.86%
Operating Profit	$298.3M	$202.5M
YoY Change	47.31%	22.43%
Interest Expense	$2.400M	$2.400M
YoY Change	0.0%	-200.0%
% of Operating Profit	0.8%	1.19%
Other Income/Expense, Net	-$2.300M	-$4.000M
YoY Change	-42.5%
Pretax Income	$293.6M	$183.3M
YoY Change	60.17%	12.8%
Income Tax	$63.40M	$40.30M
% Of Pretax Income	21.59%	21.99%
Net Earnings	$230.2M	$143.0M
YoY Change	60.98%	15.88%
Net Earnings / Revenue	26.06%	20.51%
Basic Earnings Per Share	$1.09	$0.67
Diluted Earnings Per Share	$1.06	$0.66
COMMON SHARES
Basic Shares Outstanding	211.2M shares	213.1M shares
Diluted Shares Outstanding	216.4M shares	217.8M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$918.2M	$951.8M
YoY Change	-3.53%	-30.57%
Cash & Equivalents	$819.3M	$501.4M
Short-Term Investments	$98.90M	$450.4M
Other Short-Term Assets	$105.6M	$73.60M
YoY Change	43.48%	-46.82%
Inventory	$431.4M	$356.6M
Prepaid Expenses	$53.00M	$48.80M
Receivables	$510.2M	$388.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.018B	$1.819B
YoY Change	10.94%	-19.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$588.8M	$497.3M
YoY Change	18.4%	11.73%
Goodwill	$945.2M	$630.9M
YoY Change	49.82%	71.25%
Intangibles	$402.1M	$203.7M
YoY Change	97.4%	893.66%
Long-Term Investments	$4.600M	$6.900M
YoY Change	-33.33%	-13.75%
Other Assets	$127.8M	$131.1M
YoY Change	-2.52%	145.51%
Total Long-Term Assets	$2.762B	$2.035B
YoY Change	35.76%	64.92%
TOTAL ASSETS
Total Short-Term Assets	$2.018B	$1.819B
Total Long-Term Assets	$2.762B	$2.035B
Total Assets	$4.780B	$3.854B
YoY Change	24.04%	10.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$93.00M	$78.60M
YoY Change	18.32%	14.58%
Accrued Expenses	$347.0M	$312.3M
YoY Change	11.11%	69.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$584.8M	$458.3M
YoY Change	27.6%	13.08%
LONG-TERM LIABILITIES
Long-Term Debt	$847.9M	$602.2M
YoY Change	40.8%	-0.08%
Other Long-Term Liabilities	$409.4M	$494.0M
YoY Change	-17.13%	85.37%
Total Long-Term Liabilities	$1.257B	$1.096B
YoY Change	14.7%	26.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$584.8M	$458.3M
Total Long-Term Liabilities	$1.257B	$1.096B
Total Liabilities	$2.038B	$1.555B
YoY Change	31.08%	21.97%
SHAREHOLDERS EQUITY
Retained Earnings	$4.146B	$3.480B
YoY Change	19.14%	17.35%
Common Stock	$1.451B	$1.173B
YoY Change	23.66%	11.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.672B	$2.181B
YoY Change	22.53%	31.56%
Treasury Stock Shares	32.80M shares	27.90M shares
Shareholders Equity	$2.743B	$2.299B
YoY Change
Total Liabilities & Shareholders Equity	$4.780B	$3.854B
YoY Change	24.04%	10.47%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$230.2M	$143.0M
YoY Change	60.98%	15.88%
Depreciation, Depletion And Amortization	$21.10M	$15.90M
YoY Change	32.7%	-0.63%
Cash From Operating Activities	$128.3M	$107.1M
YoY Change	19.79%	46.11%
INVESTING ACTIVITIES
Capital Expenditures	$15.90M	$27.70M
YoY Change	-42.6%	33.17%
Acquisitions	$82.00M	$0.00
YoY Change
Other Investing Activities	-$600.0K	-$4.200M
YoY Change	-85.71%	1300.0%
Cash From Investing Activities	$151.2M	$47.30M
YoY Change	219.66%	-126.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$437.4M	$344.1M
YoY Change	27.11%	240.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$391.3M	-369.1M
YoY Change	6.01%	413.35%
NET CHANGE
Cash From Operating Activities	$128.3M	107.1M
Cash From Investing Activities	$151.2M	47.30M
Cash From Financing Activities	-$391.3M	-369.1M
Net Change In Cash	-$111.8M	-214.7M
YoY Change	-47.93%	20.01%
FREE CASH FLOW
Cash From Operating Activities	$128.3M	$107.1M
Capital Expenditures	$15.90M	$27.70M
Free Cash Flow	$112.4M	$79.40M
YoY Change	41.56%	51.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	209802799	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	Edwards Lifesciences Corp
CY2016Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	35300000	USD
CY2017Q1	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	45600000	USD
CY2016Q4	ew	Accrued Rebates AccruedRebates	36100000	USD
CY2017Q1	ew	Accrued Rebates AccruedRebates	39700000	USD
CY2016Q4	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-3900000	USD
CY2017Q1	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-4700000	USD
CY2017Q1	ew	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	10200000	USD
CY2017Q1	ew	Loss Contingency Claims That If Settled Could Have A Material Adverse Impact Number LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber	1	lawsuit
CY2016Q1	ew	Payments Related To Equity Forward Contract In Accelerated Share Repurchase Agreement PaymentsRelatedToEquityForwardContractInAcceleratedShareRepurchaseAgreement	57500000	USD
CY2017Q1	ew	Payments Related To Equity Forward Contract In Accelerated Share Repurchase Agreement PaymentsRelatedToEquityForwardContractInAcceleratedShareRepurchaseAgreement	0	USD
CY2016Q1	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-4000000	USD
CY2017Q1	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-4400000	USD
CY2016Q4	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	44900000	USD
CY2017Q1	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	19300000	USD
CY2016Q4	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	40000000	USD
CY2017Q1	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	35900000	USD
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	414600000	USD
CY2017Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	510200000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	532500000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	584800000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	97100000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	93000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5900000	USD
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	132900000	USD
CY2016Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	12600000	USD
CY2017Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	11600000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-198400000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-181500000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1167800000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1207600000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14300000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15200000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9000000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8600000	USD
CY2016Q4	us-gaap	Assets Assets	4510000000	USD
CY2017Q1	us-gaap	Assets Assets	4780400000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	2240000000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	2018400000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	400000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	900000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2500000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1700000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	603000000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	577200000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	100000	USD
CY2017Q1	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	100000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2017Q1	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	96500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	96500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis	2000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	2000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	389300000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	388500000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	89400000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	89400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	600900000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	576400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	100000	USD
CY2017Q1	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	100000	USD
CY2016Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2017Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	266500000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	600000	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1100000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	31600000	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	195600000	USD
CY2016Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	16400000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12800000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	718400000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	501400000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	930100000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	819300000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-217000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-110800000	USD
CY2017Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	2300000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000.0	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000.0	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	242600000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	243200000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	211600000	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	210400000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	242600000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	243200000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	153000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	247100000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	28200000	USD
CY2017Q1	us-gaap	Cost Method Investments CostMethodInvestments	28200000	USD
CY2016Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	180300000	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	215600000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	203800000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	179100000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15900000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21100000	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3300000	USD
CY2017Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3600000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-2300000	USD
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	1000000	USD
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	216100000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	129000000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	88800000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P28M
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-200000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-36600000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4600000	USD
CY2016Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9500000	USD
CY2017Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9300000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5600000	USD
CY2017Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4600000	USD
CY2016Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	11100000	USD
CY2017Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	11100000	USD
CY2017Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1100000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	162900000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	31600000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	195600000	USD
CY2016Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	300000	USD
CY2017Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	1500000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	626100000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	945200000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	517000000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	667900000	USD
CY2016Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	238300000	USD
CY2017Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	8600000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2017Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	100000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	2400000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Six Through Ten Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	0	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	6200000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	6200000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	238200000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	8600000	USD
CY2017Q1	us-gaap	Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost	2400000	USD
CY2017Q1	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost	0	USD
CY2017Q1	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost	0	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	183300000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	293600000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40300000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63400000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	32200000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	81500000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-47600000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-94200000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	24800000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	19000000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24300000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-7000000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3700000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3600000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3600000	USD
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4700000	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5200000	shares
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	204800000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	402100000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	2400000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	2400000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	233600000	USD
CY2017Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	250900000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	396600000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	431400000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	60600000	USD
CY2017Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	65600000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	102400000	USD
CY2017Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	114900000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	33900000	USD
CY2017Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	32900000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4510000000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4780400000	USD
CY2016Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	7800000	USD
CY2017Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	8300000	USD
CY2016Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	12200000	USD
CY2017Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	10200000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	822300000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	847900000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	532100000	USD
CY2017Q1	us-gaap	Long Term Investments LongTermInvestments	519000000	USD
CY2017Q1	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-369100000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-391300000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	47300000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	151200000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	107100000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	128300000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	143000000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	230200000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	700000000	USD
CY2017Q1	us-gaap	Noncurrent Assets NoncurrentAssets	713000000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	78300000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	85200000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	111800000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	105600000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	504600000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	409400000	USD
CY2017Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	123200000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127800000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	14100000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-19600000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-6300000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	27600000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	23700000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	16900000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-300000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-500000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-4900000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1700000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000000	USD
CY2016Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	64200000	USD
CY2017Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	71500000	USD
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1300000	USD
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2000000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2300000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	2000000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-200000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4200000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-600000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	344100000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	437400000	USD
CY2016Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	73400000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	167400000	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2017Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	82000000	USD
CY2016Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	152500000	USD
CY2016Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2017Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2700000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27700000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15900000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45900000	USD
CY2017Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53000000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9700000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	377400000	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1700000	USD
CY2017Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	47700000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	193300000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	255000000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	229500000	USD
CY2016Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	19500000	USD
CY2017Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	23100000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	588800000	USD
CY2017Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	2100000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	9500000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	353400000	USD
CY2016Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2017Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	5600000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101800000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	128700000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3906300000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4145800000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	697300000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	883500000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	212700000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	229600000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14300000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15200000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	341000000	USD
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	98900000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	2619000000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	2742700000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	31000000	shares
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	32800000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2499300000	USD
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2672400000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	245500000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	144600000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	200600000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	125300000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211200000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	217800000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	216400000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	213100000	shares

Files In Submission

Name	View Source	Status
R27.htm	Edgar Link	pending
0001099800-17-000013-index-headers.html	Edgar Link	pending
0001099800-17-000013-index.html	Edgar Link	pending
0001099800-17-000013.txt	Edgar Link	pending
0001099800-17-000013-xbrl.zip	Edgar Link	pending
ew-20170331.xml	Edgar Link	completed
ew-20170331.xsd	Edgar Link	pending
ew-20170331_cal.xml	Edgar Link	unprocessable
ew-20170331_def.xml	Edgar Link	unprocessable
ew-20170331_lab.xml	Edgar Link	unprocessable
ew-20170331_pre.xml	Edgar Link	unprocessable
ew10-qq12017.htm	Edgar Link	pending
ew10-qq120_chartx55097a04.jpg	Edgar Link	pending
ew10-qq120_chartx56718a04.jpg	Edgar Link	pending
ew10-qq120_chartx58317a04.jpg	Edgar Link	pending
ew10-qq220_chartx39380a03.jpg	Edgar Link	pending
ew10-qq220_chartx39428a03.jpg	Edgar Link	pending
ew10-qq220_chartx40257a03.jpg	Edgar Link	pending
ew10-qq220_chartx40915a03.jpg	Edgar Link	pending
ew10-qq220_chartx40975a03.jpg	Edgar Link	pending
ew10-qq220_chartx43964a03.jpg	Edgar Link	pending
ew10-qq220_chartx45302a03.jpg	Edgar Link	pending
ew10-qq220_chartx46645a03.jpg	Edgar Link	pending
ex-10110xqq12017.htm	Edgar Link	pending
ex-10210xqq12017.htm	Edgar Link	pending
ex-10310xqq12017.htm	Edgar Link	pending
ex-10410xqq12017.htm	Edgar Link	pending
ex-10510xqq12017.htm	Edgar Link	pending
ex-31110xqq12017.htm	Edgar Link	pending
ex-31210xqq12017.htm	Edgar Link	pending
ex-3210xqq12017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2017 Q1 Form 10-Q Financial Statement

#000109980017000013 Filed on April 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2017 Q1 Form 10-Q Financial Statement

#000109980017000013 Filed on April 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew